A carregar...
Humanized ADEPT Comprised of an Engineered Human Purine Nucleoside Phosphorylase and a Tumor Targeting Peptide for Treatment of Cancer
Immunogenicity caused by the use of non-human enzymes in Antibody Directed Enzyme Prodrug Therapy (ADEPT) has limited its clinical application. To overcome this problem, we have developed a mutant human purine nucleoside phosphorylase (PNP), which unlike the wild-type enzyme, accepts (deoxy)adenosin...
Na minha lista:
Main Authors: | , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2009
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2707522/ https://ncbi.nlm.nih.gov/pubmed/19139128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-08-0652 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|